ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
STEPS Trial - Spheramine Safety and Efficacy Study

This study is ongoing, but not recruiting participants.
Study NCT00206687.   Last updated on October 27, 2008.   Information provided by Bayer
Please refer to this study by its ClinicalTrials.gov identifier: NCT00206687


Locations
United States, Alabama
      Birmingham, Alabama, United States, 35294
United States, California
      Los Angeles, California, United States, 90095
United States, Florida
      Tampa, Florida, United States, 33606
United States, Georgia
      Atlanta, Georgia, United States, 30322
United States, Illinois
      Chicago, Illinois, United States, 60612
United States, Kansas
      Kansas City, Kansas, United States, 66160
United States, Massachusetts
      Boston, Massachusetts, United States, 02118-2394
United States, New York
      New York, New York, United States, 10029
United States, Pennsylvania
      Philadelphia, Pennsylvania, United States, 19104
United States, Texas
      Houston, Texas, United States, 77030
Germany, Hamburg / 287
      Hamburg, Hamburg / 287, Germany, 22307
Germany, Hessen / 307
      Marburg, Hessen / 307, Germany, 35043
Germany, Saarland / 305
      Homburg, Saarland / 305, Germany, 66421
Germany, Sachsen / 313
      Dresden, Sachsen / 313, Germany, 01307
Spain
      Barcelona, Spain, 08036

Sponsors and Collaborators
Bayer
Titan Pharmaceuticals

Investigators
Study Director:     Bayer Study Director     Bayer    





Links to all studies - primarily for crawlers